Skip to content
Chr. Hansen’s current CEO, Cees the Jong, will continue as acting CEO until Mauricio Graber (photo) takes up his new position on 1 June 2018.
Chr. Hansen’s current CEO, Cees the Jong, will continue as acting CEO until Mauricio Graber (photo) takes up his new position on 1 June 2018.

Press release -

​Mauricio Graber appointed new CEO of Chr. Hansen Holding A/S

The Board of Directors of Chr. Hansen Holding A/S has today appointed Mauricio Graber as new Chief Executive Officer (CEO) as of 1 June 2018.

Mauricio Graber (54) has been President of the Flavours Division of Givaudan S.A. and a member of Givaudan’s Executive Committee since 2006.

Mauricio Graber holds a BSc in Electronic Engineering from Universidad Autónoma Metropolitana in Mexico, and a Masters in Management from the JL Kellogg Graduate School of Management, Northwestern University, USA. His professional career started in 1989 with The NutraSweet Company in the USA as Business Development Manager. After two years in the role, he returned to Mexico in 1991 to become Regional Head of North Latin America.

In 1995, he joined the US-based flavour company Tastemaker as Regional President of Latin America. In 1997, Tastemaker was acquired by the industry leader Givaudan, and subsequently Mauricio was appointed Regional President of Latin America of the combined regional business. From his new base in Brazil, he continued in that role until 2006 when he was appointed President of the Flavours division based in Switzerland. 

Over the past 10 years Mauricio has led Givaudan Flavours to strengthen its global industry leadership position. He has built a customer centric culture, accelerated commercialization of innovation, invested in developing markets, driven productivity programs, and delivered both organic growth and successful integration of strategic acquisitions. In addition, he has developed internal talents and built a strong organization.

Ole Andersen, Chairman of the Board of Directors comments: “I am delighted to announce Mauricio Graber as new CEO of Chr. Hansen as of 1 June 2018. With over 20 years of experience in the global ingredients industry, he is a truly international executive. Mauricio brings a strong track record and extensive global leadership experience from his current position. I am excited that Mauricio will take over as new CEO of Chr. Hansen and am convinced he is well suited to contribute to the continued strong performance and growth in Chr. Hansen”.

“I have followed Chr. Hansen for many years and am very impressed with its unique position and the strong results continuously being delivered. I am very excited to relocate to Copenhagen and join the Company. I really look forward to meeting and beginning to work with the Company’s leadership team and its many committed employees,” says Mauricio Graber.

Chr. Hansen’s current CEO, Cees the Jong, will continue as acting CEO until Mauricio Graber takes up his new position on 1 June 2018.

For further information, please contact:

Martin Riise, Head of Investor Relations Tel: +45 53 39 22 50

Helle Rexen, Interim Head of Media Relations, Tel: +45 20 74 28 40 

Topics


Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2016/17 financial year was EUR 1,063 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40
Kathrine Westermann

Kathrine Westermann

Press contact Head of Media Relations +45 23 81 55 95

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970 Hoersholm
Denmark